253 related articles for article (PubMed ID: 25328065)
1. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
2. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
[TBL] [Abstract][Full Text] [Related]
3. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
4. Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.
Muehleisen B; Jiang SB; Gladsjo JA; Gerber M; Hata T; Gallo RL
PLoS One; 2012; 7(7):e40754. PubMed ID: 22808251
[TBL] [Abstract][Full Text] [Related]
5. Expression of RUNX3 in skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
O'Driscoll L; McMorrow J; Doolan P; McKiernan E; Mehta JP; Ryan E; Gammell P; Joyce H; O'Donovan N; Walsh N; Clynes M
Mol Cancer; 2006 Dec; 5():74. PubMed ID: 17173689
[TBL] [Abstract][Full Text] [Related]
7. High numbers of human skin cancers express MMP2 and several integrin genes.
Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
[TBL] [Abstract][Full Text] [Related]
8. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
Bakry OA; Samaka RM; Shoeib MA; Megahed DM
Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array.
Welss T; Papoutsaki M; Michel G; Reifenberger J; Chimenti S; Ruzicka T; Abts HF
Int J Cancer; 2003 Mar; 104(1):66-72. PubMed ID: 12532421
[TBL] [Abstract][Full Text] [Related]
11. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
Hafner C; Landthaler M; Vogt T
Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.
Ghafouri-Fard S; Abbasi A; Moslehi H; Faramarzi N; Taba Taba Vakili S; Mobasheri MB; Modarressi MH
Br J Dermatol; 2010 Apr; 162(4):772-9. PubMed ID: 19886887
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma: a dermatopathological and molecular biological update.
Saldanha G; Fletcher A; Slater DN
Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
[TBL] [Abstract][Full Text] [Related]
15. Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma.
DO Carmo NG; Sakamoto LH; Pogue R; DO Couto Mascarenhas C; Passos SK; Felipe MS; DE Andrade RV
Anticancer Res; 2016 Sep; 36(9):4545-51. PubMed ID: 27630294
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
17. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
18. The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin.
Liu B; Zhang H; Li S; Chen W; Li R
Chin Med Sci J; 1996 Jun; 11(2):106-9. PubMed ID: 9387420
[TBL] [Abstract][Full Text] [Related]
19. Role of apoptosis in basal cell and squamous cell carcinoma formation.
Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
[TBL] [Abstract][Full Text] [Related]
20. Pathway analysis of expression-related SNPs on genome-wide association study of basal cell carcinoma.
Li X; Liang L; De Vivo I; Tang JY; Han J
Oncotarget; 2016 Jun; 7(24):36885-36895. PubMed ID: 27367190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
